Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

Insulin, produced by the pancreas, regulates blood glucose by facilitating its entry into cells. Various types of insulin are ...

A bolus can lower high blood sugar at other times, too. Insulin pumps provide a steady stream of short-acting and rapid-acting insulin throughout the day to keep your blood sugar levels steady.

Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been ...

Arecor Presents Positive Data From Phase I Clinical Trial Of Ultra-Concentrated Ultra-Rapid Acting Insulin At278 In ...

Insulin Aspart + Insulin Aspart Protamine is a combination of two medicines used to improve blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin ...

Africa's rapidly expanding cold chain market is projected to reach $14.85 billion by 2029, according to data from global ...

The growing incidence of diabetes, driven by sedentary lifestyles and poor dietary habits, has heightened the need for insulin therapy to effectively control blood glucose levels. Additionally ...

The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company ...